These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849 [TBL] [Abstract][Full Text] [Related]
12. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Takahashi N; Vereecke L; Bertrand MJ; Duprez L; Berger SB; Divert T; Gonçalves A; Sze M; Gilbert B; Kourula S; Goossens V; Lefebvre S; Günther C; Becker C; Bertin J; Gough PJ; Declercq W; van Loo G; Vandenabeele P Nature; 2014 Sep; 513(7516):95-9. PubMed ID: 25186904 [TBL] [Abstract][Full Text] [Related]
13. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Dillon CP; Weinlich R; Rodriguez DA; Cripps JG; Quarato G; Gurung P; Verbist KC; Brewer TL; Llambi F; Gong YN; Janke LJ; Kelliher MA; Kanneganti TD; Green DR Cell; 2014 May; 157(5):1189-202. PubMed ID: 24813850 [TBL] [Abstract][Full Text] [Related]
14. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550 [TBL] [Abstract][Full Text] [Related]
15. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Tortola L; Nitsch R; Bertrand MJM; Kogler M; Redouane Y; Kozieradzki I; Uribesalgo I; Fennell LM; Daugaard M; Klug H; Wirnsberger G; Wimmer R; Perlot T; Sarao R; Rao S; Hanada T; Takahashi N; Kernbauer E; Demiröz D; Lang M; Superti-Furga G; Decker T; Pichler A; Ikeda F; Kroemer G; Vandenabeele P; Sorensen PH; Penninger JM Cell Rep; 2016 May; 15(7):1481-1492. PubMed ID: 27160902 [TBL] [Abstract][Full Text] [Related]
16. Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death. Kist M; Kőműves LG; Goncharov T; Dugger DL; Yu C; Roose-Girma M; Newton K; Webster JD; Vucic D Cell Death Differ; 2021 Mar; 28(3):985-1000. PubMed ID: 32999468 [TBL] [Abstract][Full Text] [Related]
17. Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation. Douglas T; Saleh M J Biol Chem; 2020 Apr; 295(16):5216-5228. PubMed ID: 32122970 [TBL] [Abstract][Full Text] [Related]
18. --LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation. Zinngrebe J; Rieser E; Taraborrelli L; Peltzer N; Hartwig T; Ren H; Kovács I; Endres C; Draber P; Darding M; von Karstedt S; Lemke J; Dome B; Bergmann M; Ferguson BJ; Walczak H J Exp Med; 2016 Nov; 213(12):2671-2689. PubMed ID: 27810922 [TBL] [Abstract][Full Text] [Related]
19. TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Moujalled DM; Cook WD; Okamoto T; Murphy J; Lawlor KE; Vince JE; Vaux DL Cell Death Dis; 2013 Jan; 4(1):e465. PubMed ID: 23328672 [TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor. Etemadi N; Holien JK; Chau D; Dewson G; Murphy JM; Alexander WS; Parker MW; Silke J; Nachbur U FEBS J; 2013 Nov; 280(21):5283-97. PubMed ID: 23815148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]